 VALSARFEC D
|
Fecofar
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.x 30 | $33.082,04 | (29/09/26) |
| PAMI |
|
| AF $15.855,17 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $13.682,10 |
|
|
|
|
| 160/25 mg comp.x 30 | $38.429,95 | (29/09/26) |
| PAMI |
|
| AF $17.319,44 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $14.174,63 |
|
|
|
|
| 80/12.5 mg comp.x 30 | $28.498,13 | (29/09/26) |
| PAMI |
|
| AF $14.249,07 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $10.739,13 |
|
|
|
|
| 80/12.5 mg comp.x 28 | $26.849,10 | (29/09/26) |
|
|
|
| 160/12.5 mg comp.x 28 | $31.167,72 | (29/09/26) |
| PAMI |
|
| AF $15.583,86 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $15.400,51 |
|
|
|
|
| 160/25mg comp.x 28 | $36.206,20 | (29/09/26) |
| PAMI |
|
| AF $18.103,10 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $20.438,99 |
|
|
|
|
| |
